Sigma-Aldrich offers raw materials with pedigree; P&G targets 5,700 non-manufacturing jobs;

> Sigma-Aldrich ($SIAL) says it is responding to higher regulatory scrutiny that its clients face by releasing 25 new raw materials to its portfolio that feature regulatory support documentation for every lot. Release

> Boehringer Ingelheim and BaroFold have struck a non-exclusive technology and commercial license option agreement in which Boehringer will acquire a laboratory-scale reactor of BaroFold's Pressure Enabled Manufacturing Technology that can also be qualified for GMP use. Release

> Chemical distributor and supply chain services provider Doe & Ingalls has received a distilled spirits plant permit, which allows the company to warehouse and ship tax-free ethyl alcohol (ethanol). Doe & Ingalls will serve its customers through its three bonded service centers in California, North Carolina and Maryland. Item

> HumanZyme will provide HumanKine growth factors and cytokines to PacificGMP to manufacture recombinant human proteins intended for human clinical use. Item

And Finally... Procter & Gamble ($PG) will whack 5,700 non-manufacturing jobs to save money but expects to increase its manufacturing production 5%. Release

Suggested Articles

Hikma says it has picked up some pipeline products and nasal and sublingual spray equipment from Insys Therapeutics' bankruptcy.

WuXi Biologics expects to have a plant in Europe complete in 2021 as a capacity race plays out among Asia’s rapidly growing biologics CDMOs.

After five years of struggles, Sun Pharmaceutical has put the problems at its key plant in Halol, India behind it.